These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 9764822

  • 1. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL, Hicks GG, Hsieh FF, Prasher JM, Green WF, Miller MD, Eide EJ, Ruley HE.
    Oncogene; 1998 Sep 03; 17(9):1119-30. PubMed ID: 9764822
    [Abstract] [Full Text] [Related]

  • 2. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT, Wessely O, Pironin M, Beug H, Ghysdael J.
    EMBO J; 1997 Sep 15; 16(18):5639-53. PubMed ID: 9312023
    [Abstract] [Full Text] [Related]

  • 3. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS, Li YJ, Howard J, Ben-David Y.
    Oncogene; 1999 Sep 30; 18(40):5525-34. PubMed ID: 10523829
    [Abstract] [Full Text] [Related]

  • 4. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ.
    Cancer Res; 2001 Apr 15; 61(8):3373-81. PubMed ID: 11309295
    [Abstract] [Full Text] [Related]

  • 5. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
    Katoh I, Aisaki KI, Kurata SI, Ikawa S, Ikawa Y.
    Oncogene; 2000 Jun 22; 19(27):3126-30. PubMed ID: 10871867
    [Abstract] [Full Text] [Related]

  • 6. The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1.
    Vairapandi M, Balliet AG, Fornace AJ, Hoffman B, Liebermann DA.
    Oncogene; 1996 Jun 20; 12(12):2579-94. PubMed ID: 8700517
    [Abstract] [Full Text] [Related]

  • 7. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM, Elenitoba-Johnson KS, Kelley LL.
    Oncogene; 2001 May 24; 20(23):2946-55. PubMed ID: 11420707
    [Abstract] [Full Text] [Related]

  • 8. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y.
    Cancer Res; 1994 Mar 01; 54(5):1169-74. PubMed ID: 8118801
    [Abstract] [Full Text] [Related]

  • 9. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S, el-Deiry WS, Bae I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW, O'Connor PM.
    Cancer Res; 1994 Nov 15; 54(22):5824-30. PubMed ID: 7954409
    [Abstract] [Full Text] [Related]

  • 10. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
    Howard JC, Li Q, Chu W, Zochodne B, Kapoor M, Ung Y, Rosen K, Ben-David Y.
    Oncogene; 2001 Apr 26; 20(18):2291-300. PubMed ID: 11402324
    [Abstract] [Full Text] [Related]

  • 11. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C, Claudio PP, Luca AD, Cuccurese M, Howard CM, D'Esposito M, Paggi MG, Sala DL, Azzoni L, Halazonetis TD, Giordano A, Maraldi NM.
    Oncogene; 2000 Oct 19; 19(44):5098-105. PubMed ID: 11042698
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K, Ehinger M, Svedberg H, Gullberg U.
    Cell Growth Differ; 2000 Nov 19; 11(11):561-71. PubMed ID: 11095245
    [Abstract] [Full Text] [Related]

  • 13. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
    Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M.
    Oncogene; 2001 Jan 18; 20(3):320-8. PubMed ID: 11313961
    [Abstract] [Full Text] [Related]

  • 14. Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells.
    Gottlieb E, Lindner S, Oren M.
    Cell Growth Differ; 1996 Mar 18; 7(3):301-10. PubMed ID: 8838860
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.